ccws candida cleanser treatment guide

CCWS 45 Day Candida Supplement

Chitin Synthesis Inhibitor –  Candida Cell Wall Suppressor Treatment Technical Data

“I discovered Candida Cleanser through a recommendation and took one course with great results”
Emma from Australia

Lufenuron the active ingredient in CCWS was originally developed and patented by Novartis, we can only come to one conclusion as to why they have shut down production and release of this treatment.  We have to bear in mind the yeast and candida treatment business is worth billions to big pharma, not to mention the cancer industry being the most lucrative of all!

Field of The Invention

The present invention relates to a new use of benzoylphenylureas derivatives. More particularly, the present invention relates to benzoylphenylureas derivatives for use in combating fungal infections.

Background of the Invention

Fungi are causative agents of various superficial skin lesions. The fungi live on the surface of the skin and use keratin as major solutions of nutrients. Fungi are found on various skin regions including in the legs, in the genital area, below the nails, etc. In addition, occasionally, particularly in individuals with immune deprivation, fungi can develop on various other tissues such as on the oral mucosa. Furthermore, there are occasional fungi infections which may be systemic. The fungi cells are typically surrounded by cell walls that contain complex polysaccharides, primarily chitin, chitosan, glucans and mannans. U.S. Pat. No. 4,798,837, discloses N-benzoyl-N’-2,5-dichloro-4-hexafluoropropyloxy-phenylureas which were found to be effective. One of these compounds, known by the generic name is Lufenuron

lufenuron candida cleanser ingresinet

General Description of The Invention

In accordance with the invention it was found that Lufenuron administration is effective in combating and controlling fungal infection, especially such caused by dermatophytes. The term “effective amount” should be understood as meaning an amount effective in achieving a therapeutic effect which may be manifested either in a permanent or temporary improvement in the subject’s condition, or in reduction of a fungal infection load. The effective amount may depend, inter alia, on the therapeutic regiment, the type of infection being treated, namely whether it is systemic, topical, etc., on the type of subject treated, i.e. whether it is human or a non human animal, as well as the type of animal, on the age of the subject, etc. The pharmaceutical composition of the invention may, for example be provided in the form of a powder, lyophilizate, etc., for mixing with a physiological solution, e.g. saline for the purpose of parenteral administration. By a further example, the pharmaceutical solution of the invention may be formulated as an oral dosage form, e.g. in the form of a pill or a capsule. In addition, for some applications, the pharmaceutical composition of the invention may also be formulated in the form of a liquid solution intended for oral administration. Furthermore, the composition of the invention may also be formulated for topical administration. The invention allows a therapeutic treatment of a variety of fungal infections. These may include systemic infections as well as topical fungal infections. In particular, and by a preferred embodiment, the present invention allows treatment of skin fungal infections in both humans and animals, nail or genital fungal infections in humans, eye fungal infections or ear fungal infections in both humans and animals, and others. Particular examples of fungal infections which may be treated in accordance with the invention are caused by dermatophytes such as those of the genus Microsporum (e.g. Microsporum Canis) which cause various skin fungal infections of the skin, nails or hair; those of the genus Aspergillas, and yeasts, e.g. Malassezia or Candida.

How our CCWS Candida Supplement Works

candida cleanser treatment

CCWS Candida Cleanser a Chitin Synthesis Inhibitor The CCWS treatment works on Candida Albicans Yeast Fungus much like antibiotics work on bacteria, by destroying the cell wall that protects the invaders. Imagine it like this, the Candida is wearing a strong protective armor, and as long as it has the hard protective coating our immune system cannot adequately handle it. Now, when the hard armor is removed, the whole integrity of the Candida has been disrupted. Since the yeast cells can’t produce their hard protective shell it will either die or be destroyed by the immune system. Our treatment is called CCWS Candida Cleanser and uses chitin synthesis inhibitor to destroy the chitin that the yeast use in their cell walls for protection. When the Candida is not able to produce this substance, it will die, much like bacteria die when you take antibiotics. Since the human body does not use chitin in any way, the medication does not produce any adverse side effects.

Is CCWS Candida Cleanser Safe?

Since humans do not produce or use chitin in any way, CCWS treatment is inert in the human body. What this means is that our treatment is equivalent to taking activated charcoal, the compound simply does not affect the human body. Our compound has been tested for many years in mammals, in massive dosages, and has shown no adverse effects. The problem with many traditional fungicides used in modern medicine is that they can have side-effects on the body and adversely affect the liver and kidneys. However, with our treatment it is non-toxic to the human body.

If you’re still worried about CCWS Candida Cleanser being safe or not, here’s the original Patent on Lufenuron: http://www.google.co.uk/patents/US6110971

In their words: “The invention allows a therapeutic treatment of a variety of fungal infections. These may include systemic infections as well as topical fungal infections. In particular, and by a preferred embodiment, the present invention allows treatment of skin fungal infections in both humans and animals, nail or genital fungal infections in humans, eye fungal infections or ear fungal infections in both humans and animals, and others. Particular examples of fungal infections which may be treated in accordance with the invention are caused by dermatophytes such as those of the genus Microsporum (e.g. Microsporum Canis) which cause various skin fungal infections of the skin, nails or hair; those of the genus Aspergillas, and yeasts, e.g. Malassezia or Candida.” In order for this patent to be filed, the drug company would have gone through rigorous testing to insure the safety. It is a non-toxic substance for all mammals, including humans. If you find anything online that claims Lufenuron does not treat fungal infection, you’re being duped. There are powerful organizations who do not want us to know about this as it threatens their bottom line. This patent expired in 2008 and this is why we now have it available, but since the original drug company who made it did not seek FDA approval, it remains in a gray zone with FDA, thus the company must be based outside of the US. candida cell wall suppresor for fungal yeast infection

What are the Ingredients of CCWS Candida Cleanser

ccws cell wall suppressor supplement ingredients Supplement Facts: CCWS Candida Cleanser primary ingredient is a proprietary blend of Lufenuron (Chitin Synthesis Inhibitor), rice & seaweed

“I had been sick for more than 10 years and now I feel wonderful! ”
Carolyn from USA